These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28612303)

  • 1. Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.
    Frommeyer G; Fischer C; Ellermann C; Dechering DG; Kochhäuser S; Lange PS; Wasmer K; Fehr M; Eckardt L
    Cardiovasc Toxicol; 2018 Feb; 18(1):84-90. PubMed ID: 28612303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone.
    Frommeyer G; Fischer C; Ellermann C; Lange PS; Dechering DG; Kochhäuser S; Fehr M; Eckardt L
    Cardiovasc Toxicol; 2017 Oct; 17(4):451-457. PubMed ID: 28185059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome.
    Frommeyer G; Weller J; Ellermann C; Leitz P; Kochhäuser S; Lange PS; Dechering DG; Eckardt L
    Cardiovasc Toxicol; 2019 Apr; 19(2):129-135. PubMed ID: 30238354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Ellermann C; Sterneberg M; Kochhäuser S; Dechering DG; Fehr M; Eckardt L; Frommeyer G
    Europace; 2018 Oct; 20(10):1699-1706. PubMed ID: 29377987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.
    Frommeyer G; von der Ahe H; Brücher B; Dechering DG; Lange PS; Reinke F; Wasmer K; Köbe J; Pott C; Mönnig G; Eckardt L
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1073-80. PubMed ID: 27405774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent electrophysiologic profile of fluconazole and voriconazole in an experimental whole-heart model of proarrhythmia.
    Frommeyer G; Fischer C; Lange PS; Leitz P; Fehr M; Bogossian H; Milberg P; Eckardt L
    Eur J Pharmacol; 2016 Apr; 776():185-90. PubMed ID: 26905475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
    Milberg P; Hilker E; Ramtin S; Cakir Y; Stypmann J; Engelen MA; Mönnig G; Osada N; Breithardt G; Haverkamp W; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):647-54. PubMed ID: 17388913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad antiarrhythmic effect of mexiletine in different arrhythmia models.
    Frommeyer G; Garthmann J; Ellermann C; Dechering DG; Kochhäuser S; Reinke F; Köbe J; Wasmer K; Eckardt L
    Europace; 2018 Aug; 20(8):1375-1381. PubMed ID: 29016765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.
    Frommeyer G; Krawczyk J; Ellermann C; Bögeholz N; Kochhäuser S; Dechering DG; Fehr M; Eckardt L
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):471-476. PubMed ID: 29314443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit Hearts.
    Wolfes J; Ellermann C; Burde S; Leitz P; Bögeholz N; Willy K; Fehr M; Eckardt L; Frommeyer G
    Cardiovasc Toxicol; 2020 Dec; 20(6):531-538. PubMed ID: 32500385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer's Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model.
    Ellermann C; Coenen A; Niehues P; Leitz P; Kochhäuser S; Dechering DG; Fehr M; Eckardt L; Frommeyer G
    Cardiovasc Toxicol; 2020 Apr; 20(2):168-175. PubMed ID: 31302839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological profile of vernakalant in an experimental whole-heart model: the absence of proarrhythmia despite significant effect on myocardial repolarization.
    Frommeyer G; Milberg P; Clauss C; Schmidt M; Ramtin S; Kaese S; Grundmann F; Grotthoff JS; Pott C; Eckardt L
    Europace; 2014 Aug; 16(8):1240-8. PubMed ID: 24696223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.
    Milberg P; Ramtin S; Mönnig G; Osada N; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):278-86. PubMed ID: 15475823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propofol abolishes torsade de pointes in different models of acquired long QT syndrome.
    Ellermann C; Könemann H; Wolfes J; Rath B; Wegner FK; Willy K; Dechering DG; Reinke F; Eckardt L; Frommeyer G
    Sci Rep; 2020 Jul; 10(1):12133. PubMed ID: 32699382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbances of cardiac wavelength and repolarization precede Torsade de Pointes and ventricular fibrillation in Langendorff perfused rabbit hearts.
    Hondeghem LM
    Prog Biophys Mol Biol; 2016 May; 121(1):3-10. PubMed ID: 26980523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers.
    Milberg P; Fleischer D; Stypmann J; Osada N; Mönnig G; Engelen MA; Bruch C; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2007 Jan; 102(1):42-51. PubMed ID: 16817026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
    Milberg P; Reinsch N; Osada N; Wasmer K; Mönnig G; Stypmann J; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Jul; 100(4):365-71. PubMed ID: 15944809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic effects of free polyunsaturated fatty acids in an experimental model of LQT2 and LQT3 due to suppression of early afterdepolarizations and reduction of spatial and temporal dispersion of repolarization.
    Milberg P; Frommeyer G; Kleideiter A; Fischer A; Osada N; Breithardt G; Fehr M; Eckardt L
    Heart Rhythm; 2011 Sep; 8(9):1492-500. PubMed ID: 21459164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
    Frommeyer G; Milberg P; Witte P; Stypmann J; Koopmann M; Lücke M; Osada N; Breithardt G; Fehr M; Eckardt L
    Eur J Heart Fail; 2011 Oct; 13(10):1060-9. PubMed ID: 21873342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.